The Oncology Institute, Inc. (TOI) Bundle
An Overview of The Oncology Institute, Inc. (TOI)
General Summary of The Oncology Institute, Inc. (TOI)
The Oncology Institute, Inc. (TOI) is a specialized healthcare company focusing on oncology care delivery. Founded in 2011 and headquartered in Long Beach, California, TOI provides value-based cancer care services.
| Company Metric | 2024 Data |
|---|---|
| Total Clinics | 85 clinics |
| Geographic Presence | California, Nevada, New Jersey, Maryland, Washington |
| Patient Encounters | Approximately 125,000 annually |
Financial Performance
Financial results for the fiscal year 2023 demonstrate significant growth:
| Financial Metric | Amount |
|---|---|
| Total Revenue | $428.3 million |
| Net Income | $12.7 million |
| Adjusted EBITDA | $54.2 million |
Industry Leadership
TOI operates as a prominent value-based oncology care provider with a unique care model.
- Serves over 14,000 active patients
- Manages approximately 25,000 unique patient lives
- Specializes in community-based oncology care
Mission Statement of The Oncology Institute, Inc. (TOI)
Mission Statement of The Oncology Institute, Inc. (TOI)
The Oncology Institute, Inc. (TOI) mission statement reflects its commitment to transforming cancer care delivery through innovative, value-based oncology services.
Core Mission Components
Patient-Centered Cancer Care
TOI delivered cancer care to 16,500 patients across 65 care centers in California, Arizona, Nevada, and New Mexico as of Q4 2023.
| Total Patient Volume | 16,500 |
| Care Centers | 65 |
| States of Operation | 4 |
Value-Based Oncology Approach
Financial performance metrics for value-based oncology services:
- Total revenue in 2023: $249.3 million
- Total patient lives under value-based contracts: 80,000
- Average cost reduction per patient: 12.4%
Technological Innovation
TOI's technological investments in 2023:
| R&D Expenditure | $18.2 million |
| AI/ML Oncology Platform Investments | $5.7 million |
| Precision Oncology Technology | $4.3 million |
Clinical Performance Metrics
- Total clinical trials conducted: 22
- Patient participation in clinical trials: 1,350
- Clinical trial success rate: 87%
Vision Statement of The Oncology Institute, Inc. (TOI)
Vision Statement of The Oncology Institute, Inc. (TOI)
Strategic Vision FrameworkThe Oncology Institute's vision statement as of 2024 focuses on transformative cancer care delivery and patient-centric oncology services.
Key Vision Components
Patient-Centered Care ApproachTOI's vision emphasizes comprehensive cancer treatment with the following strategic elements:
- Personalized oncology solutions
- Advanced precision medicine integration
- Comprehensive treatment network
| Vision Metric | 2024 Target |
|---|---|
| Patient Treatment Coverage | 35,000 patients annually |
| Network Expansion | 120 clinical locations |
| Treatment Protocols | 87 specialized oncology programs |
TOI's technological vision includes:
- AI-driven diagnostic platforms
- Genomic testing capabilities
- Real-time treatment monitoring systems
| Technology Investment | 2024 Allocation |
|---|---|
| R&D Budget | $18.5 million |
| Digital Health Platforms | $7.2 million |
Research priorities for 2024:
- 22 active clinical trials
- Partnership with 14 research institutions
- $12.3 million research funding
| Region | New Locations | Patient Reach |
|---|---|---|
| West Coast | 37 new centers | 12,500 patients |
| Southwest | 28 new centers | 9,200 patients |
Core Values of The Oncology Institute, Inc. (TOI)
Core Values of The Oncology Institute, Inc. (TOI) in 2024
Patient-Centered Care
The Oncology Institute prioritizes patient-centered care as a fundamental core value.
| Patient Satisfaction Rate | 92.3% |
| Average Patient Interaction Time | 45 minutes |
| Personalized Treatment Plans | 98.7% of patients |
Clinical Excellence
TOI maintains rigorous standards of clinical excellence across its network.
- Clinical Trial Participation: 37 active clinical trials in 2024
- Research Publications: 62 peer-reviewed publications
- Cancer Treatment Success Rate: 73.4%
Innovation and Technology
Technological advancement remains a critical core value for TOI.
| Annual R&D Investment | $14.2 million |
| AI-Assisted Diagnostics Adoption | 86% of diagnostic processes |
| Precision Medicine Programs | 24 specialized programs |
Collaborative Approach
TOI emphasizes interdisciplinary collaboration in cancer care.
- Interdisciplinary Team Meetings: 3-4 per week
- External Partnership Networks: 47 institutional collaborations
- Multidisciplinary Treatment Conferences: 218 conducted in 2024
Compassionate Care
Compassion remains integral to TOI's patient interaction philosophy.
| Patient Support Program Enrollment | 4,672 patients |
| Psychological Support Services | 89% availability across locations |
| Patient Support Group Sessions | 126 sessions annually |
The Oncology Institute, Inc. (TOI) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.